Cargando...
1α,25-dihydroxyvitamin D(3) promotes osseointegration of titanium implant via downregulating AGEs/RAGE pathway in T2DM
Diabetes-induced advanced glycation end products (AGEs) overproduction would result in compromised osseointegration of titanium implant and high rate of implantation failure. 1α,25-dihydroxyvitamin D(3) (1,25VD(3)) plays a vital role in osteogenesis, whereas its effects on the osseointegration and t...
Guardado en:
| Publicado en: | Endocr Connect |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Bioscientifica Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215803/ https://ncbi.nlm.nih.gov/pubmed/30352411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0241 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|